2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Рекомендации ESC 2014 года по диагностике и лечению гипертрофической кардиомиопатии
2014-08-29
SCID: 54.1/23vu3jbf
Discuss with AI
ESC Guidelinesdiagnosishypertrophic cardiomyopathymanagement
Figures from the paper
Abstract (AI)
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their dating.The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relationship to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies.However, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC Guidelines exempt health professionals from taking careful and full consideration of the relevant official updated recommendations or guidelines issued by the competent public health authorities in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
Key Findings
1
The abstract text is incomplete and provides no specific diagnostic recommendations, management strategies, evidence grading, or outcome data.
2
The guidelines are associated with the European Society of Cardiology and the Heart Failure Association of the ESC.
3
The provided text identifies ESC guidelines addressing the diagnosis and management of hypertrophic cardiomyopathy.
Research Object
Guidelines for diagnosis and management of hypertrophic cardiomyopathy issued by the European Society of Cardiology (ESC)
Research Subject
Recommendations and evidence-based strategies for diagnosing and managing hypertrophic cardiomyopathy
Publication Details
Publication Date
2014-08-29
Journal
Publisher
ISSN
Cited by
4332
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by13
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2021
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2016
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS2016
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS2016
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure2016
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death2015
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death2022
2023 ESC Guidelines for the management of cardiomyopathies2023
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy2018
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure2022
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease2020
Myocardial strain imaging: how useful is it in clinical decision making?2015
Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology2019